AstraZeneca plc (LON:AZN) had its Reduce rating reiterated by HSBC

Analyst Ratings For AstraZeneca plc (LON:AZN)

Story continues below

Today, HSBC reiterated its Reduce rating on AstraZeneca plc (LON:AZN).

There are 9 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AstraZeneca plc (LON:AZN) is Hold with a consensus target price of GBX 7,062.50 per share, a potential .

Some recent analyst ratings include

  • 10/1/2019-AstraZeneca plc (LON:AZN) had its Reduce rating reiterated by HSBC
  • 9/30/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital
  • 9/30/2019-AstraZeneca plc (LON:AZN) had its Sell rating reiterated by UBS Group
  • 9/30/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Deutsche Bank with a GBX 7,800 price target
  • 9/20/2019-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Liberum Capital

    Recent Trading Activity for AstraZeneca plc (LON:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 7,181.00 −80.00 1.10% with 44.78 shares trading hands.

    An ad to help with our costs